BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2528664)

  • 1. N-glycosidase treatment of Colo 205 cells interferes with hIFN-gamma induced HLA-DR expression.
    Fischer T; Wiegmann K; Pfizenmaier K
    Lymphokine Res; 1989; 8(3):305-9. PubMed ID: 2528664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of interferon receptor expression during combination beta ser-interferon and gamma-interferon treatment of human colon carcinoma cells.
    Schiller JH; Bushmeyer SM; Ruzicka FJ; Princler GL; Faltynek CR; Borden EC
    Cancer Res; 1990 Jan; 50(1):26-31. PubMed ID: 2136700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-1 and tumor necrosis factor-alpha each up-regulate both the expression of IFN-gamma receptors and enhance IFN-gamma-induced HLA-DR expression on human monocytes and a human monocytic cell line (THP-1).
    Krakauer T; Oppenheim JJ
    J Immunol; 1993 Feb; 150(4):1205-11. PubMed ID: 8432976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of MHC class II molecules HLA-DR, -DP and -DQ and ICAM 1 in human podocytes by gamma-interferon.
    Baudeau C; Delarue F; Hé CJ; Nguyen G; Adida C; Peraldi MN; Sraer JD; Rondeau E
    Exp Nephrol; 1994; 2(5):306-12. PubMed ID: 7812737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta.
    Shaw AR; Chan JK; Reid S; Seehafer J
    J Natl Cancer Inst; 1985 Jun; 74(6):1261-8. PubMed ID: 3923246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interferon-gamma receptor in human monocytes is different from the one in nonhematopoietic cells.
    Orchansky P; Rubinstein M; Fischer DG
    J Immunol; 1986 Jan; 136(1):169-73. PubMed ID: 2933462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of recombinant human fibroblast interferon and mezerein on growth, differentiation, immune interferon binding and tumor associated antigen expression in human melanoma cells.
    Fisher PB; Hermo H; Solowey WE; Dietrich MC; Edwalds GM; Weinstein IB; Langer JA; Pestka S; Giacomini P; Kusama M
    Anticancer Res; 1986; 6(4):765-74. PubMed ID: 2944474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation by thyroid hormone of human IFN-gamma-induced HLA-DR expression.
    Lin HY; Martino LJ; Wilcox BD; Davis FB; Gordinier JK; Davis PJ
    J Immunol; 1998 Jul; 161(2):843-9. PubMed ID: 9670962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of human recombinant alpha 2 arg-interferon and gamma-interferon on human breast cancer cell lines: dissociation of antiproliferative activity and induction of HLA-DR antigen expression.
    Gastl G; Marth C; Leiter E; Gattringer C; Mayer I; Daxenbichler G; Flener R; Huber C
    Cancer Res; 1985 Jul; 45(7):2957-61. PubMed ID: 3924395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosylation of the human interferon-gamma receptor. N-linked carbohydrates contribute to structural heterogeneity and are required for ligand binding.
    Fischer T; Thoma B; Scheurich P; Pfizenmaier K
    J Biol Chem; 1990 Jan; 265(3):1710-7. PubMed ID: 2136857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of HLA-DR antigen expression by gamma-interferon: separate signal transduction mechanisms in malignant and nonmalignant human thyroid cells.
    Lahat N; Sobel E; Kraiem Z
    Cancer Res; 1993 Sep; 53(17):3943-7. PubMed ID: 8358721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of lymphocyte adhesion to human vascular endothelial cells in culture. T lymphocyte adhesion to endothelial cells through endothelial HLA-DR antigens induced by gamma interferon.
    Masuyama J; Minato N; Kano S
    J Clin Invest; 1986 May; 77(5):1596-605. PubMed ID: 3084562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding and cross-linking of recombinant mouse interferon-gamma to receptors in mouse leukemic L1210 cells; interferon-gamma internalization and receptor down-regulation.
    Wietzerbin J; Gaudelet C; Aguet M; Falcoff E
    J Immunol; 1986 Apr; 136(7):2451-5. PubMed ID: 2936825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes.
    Tsujisaki M; Igarashi M; Sakaguchi K; Eisinger M; Herlyn M; Ferrone S
    J Immunol; 1987 Feb; 138(4):1310-6. PubMed ID: 3100635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutting edge: phorbol ester induction of IFN-gamma receptors leads to enhanced DR alpha gene expression.
    Sakamoto S; Nie J; Taniguchi T
    J Immunol; 1999 Apr; 162(8):4381-4. PubMed ID: 10201972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-gamma modulates HLA class II antigen expression on cultured human thymic epithelial cells.
    Berrih S; Arenzana-Seisdedos F; Cohen S; Devos R; Charron D; Virelizier JL
    J Immunol; 1985 Aug; 135(2):1165-71. PubMed ID: 3925000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
    Geppert TD; Lipsky PE
    J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma.
    Guerry D; Alexander MA; Elder DE; Herlyn MF
    J Immunol; 1987 Jul; 139(1):305-12. PubMed ID: 3108402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of class I and class II histocompatibility antigens on human T cell lines by IFN-gamma.
    Gerrard TL; Dyer DR; Zoon KC; zur Nedden D; Siegel JP
    J Immunol; 1988 May; 140(10):3450-5. PubMed ID: 2966196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of the induction of HLA-DR expression by human immune interferon on glioma cell lines and their clones.
    Piguet V; Carrel S; Diserens AC; Mach JP; de Tribolet N
    J Natl Cancer Inst; 1986 Feb; 76(2):223-8. PubMed ID: 3080635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.